•    Appointment of the acting Director of the Department of Global Health

Sylvain Brisse has been appointed as acting Director of the Department of Global Health from November 1 to December 31, 2026.

More information in decision memo 1497 (in French)

 
•    Extension of the Interactomics, RNA and immunity laboratory

The term of the Interactomics, RNA and Immunity laboratory, led by Caroline Demeret, has been extended to December 31, 2027.

More information in decision memo 1498 (in French)

•    Extension of the Evolutionary cell biology and evolution of morphogenesis five-year group

The term of the Evolutionary cell biology and evolution of morphogenesis five-year group, led by Thibaut Brunet, has been extended to September 30, 2027.

More information in decision memo 1499 (in French)
 

• Appointment of the scientific coordinator and deputy coordinator for the Lwoff 1 BSL3 laboratory

In view of the Institut Pasteur's regulation on biological safety in BSL3 containment laboratories, updated in December 2020:

Isabelle Staropoli and Delphine Planas have been respectively appointed as scientific coordinator and deputy scientific coordinator of the Lwoff 1 BSL3 laboratory on the first floor of the Lwoff building.

Scientific coordinators of BSL3 laboratories (or their deputies if they are absent) are responsible for making sure that users are familiar with and apply the biological safety regulations for BSL3 containment laboratories. In the event of a dispute concerning one or more users, they share their observations with the heads of unit and heads of laboratory concerned, and/or the Risk Prevention Department, so that they can take appropriate measures.

More information in decision memo 1500 (in French)

•    New Myeloid Cells, Inflammation and Aging five-year group (G5)

Following the favorable opinion issued by the Scientific Council in June 2025, in October 2026 the Board of Governors approved the proposal by the President to establish the Myeloid Cells, Inflammation and Aging five-year group (G5) as from November 1, 2026.

This G5, part of the Department of Immunology, will be directed by Nader Yatim, an Expert Research Associate at the Institut Pasteur.

More information in memo 058 (in French)

•    Closure of the Fungal Heterogeneity five-year group (G5)

At its session in October 2026, the Board of Governors approved the closure as from August 31, 2026 of the Fungal Heterogeneity five-year group (G5), led by Iuliana Ene, which had come to the end of its term.

More information in memo 059 (in French)

•    Appointment of the Director of the Department of Cell Biology and Infection

At its session on October 14, 2026, the Board of Governors appointed Mélanie Hamon as Director of the Department of Cell Biology and Infection for a five-year period from October 14, 2026, renewable under the conditions set out in the Institut Pasteur's Internal Regulations.

More information in memo 060 (in French)